Tissue & Organ Applications
Tengion’s technology platform has been applied to the following organs and tissue systems. Initially, the company will focus on the genitourinary and cardiovascular systems.
 |
 |
 |
 |
|
 |
 |
 |
||
 |
 |
 |
||
 |
|
|
|
|
Featured Information
Latest News
- September 22, 2008: Tengion Announces Expanded European Orphan Medicinal Product Designation for Neo-Bladder Augment
- September 22, 2008: Tengion Appoints Brian J. G. Pereira, M.D. to its Board of Directors
- September 19, 2008: Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
- September 18, 2008: Tengion Scientists Publish Positive Preclinical Findings with Neo-Organ Demonstrating Long-term Durability and Growth with Skeletal Maturation